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Background: When medically unexplained physical symptoms (MUPS) become persistent, it may have major
implications for the patient, the general practitioner (GP) and for society.
Early identification of patients with MUPS in electronic medical records (EMRs) might contribute to prevention of
persistent MUPS by creating awareness among GPs and providing an opportunity to start stepped care
management. However, procedures for identification of patients with MUPS in EMRs are not well established yet. In
this validation study we explore the test characteristics of an EMR screening method to identify patients with MUPS.
Methods: The EMR screening method consists of three steps. First, all patients ≥18 years were included when they
had five or more contacts in the last 12 months. Second, patients with known chronic conditions were excluded.
Finally, patients were included with a MUPS syndrome or when they had three or more complaints suggestive for
MUPS. We compared the results of the EMR screening method with scores on the Patient Health Questionnaire-15
(PHQ-15), which we used as reference test. We calculated test characteristics for various cut-off points.
Results: From the 1223 patients in our dataset who completed the PHQ-15, 609 (49/8%) scored ≥5 on the PHQ-15.
The EMR screening method detected 131/1223 (10.7%) as patients with MUPS. Of those, 102 (77.9%) scored ≥5
on the PHQ-15 and 53 (40.5%) scored ≥10. When compared with the PHQ-15 cut-off point ≥10, sensitivity and
specificity were 0.30 and 0.93 and positive and negative predictive values were 0.40 and 0.89, respectively.
Conclusions: The EMR screening method to identify patients with MUPS has a high specificity. However, many
potential MUPS patients will be missed. Before using this method as a screening instrument for selecting patients
who might benefit from structured care, its sensitivity needs to be improved while maintaining its specificity.Background
Presentation of medically unexplained physical symp-
toms (MUPS) is a common phenomenon in primary
care. Of all primary care encounters, in up to a third the
symptoms presented by the patient remain unexplained
[1,2]. In specialist care, these figures may even be higher,
depending on the specialty [3]. Although MUPS become
persistent in only a minority (2.5%) of patients, the bur-
den of persistent MUPS is high for both patients and
doctors and for society [4]. Patients are functionally* Correspondence: m.denboeft@vumc.nl
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unless otherwise stated.impaired and may feel that they are not taken seriously
by their general practitioner (GP) [5-7]. Furthermore,
the doctor-patient relationship is often troubled and
many GPs indicate that they find these patients difficult
to manage [8,9]. Also persistent MUPS may lead to high
and inadequate health care utilization and high associ-
ated costs [10-12].
Early identification of patients with a higher risk of de-
veloping persistent MUPS in routine electronic medical
records (EMRs) could create an opportunity for pro-
active and structured care, taking into account the sever-
ity of MUPS, coordinated by GPs. Awareness among
GPs of their population at risk could result in more at-
tention during consultations or in offering effective in-
terventions like cognitive behaviour therapy at an earlierral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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is that the data are directly available and no additional
data collection is needed, which saves time consuming
logistical procedures. Furthermore it provides a quick
overview of a population at risk.
Early identification in EMRs proved to be feasible and
effective for other risk populations, like patients with type
2 diabetes, cardiovascular risks and frail elderly [14-16] as
well as for preventive health care [17]. Also Tian et al. de-
veloped an applicable EMR algorithm to identify patients
with chronic pain [18]. However, identifying patients with
MUPS is not an easy task as there is no generally accepted
procedure available. Although some MUPS characteristics,
like frequent consultation and referral rate, can be ob-
tained from EMRs, there is no international classification
of primary care (ICPC) code available that identifies the
combination of symptoms that characterise MUPS of vari-
ous MUPS subgroups.
Morriss et al. developed an EMR model that estimates
the prevalence of MUPS. However, they concluded that
the model is not useful for screening purposes due to a
low sensitivity [19]. Various other methods for MUPS
screening have been developed and studied. Kroenke et al.
showed in their validation study that the self-administered
Patient Health Questionnaire-15 (PHQ-15) could be used
for screening somatisation and somatic symptom severity
including MUPS [20]. However, the PHQ-15 can not be
easily obtained from EMRs. Verhaak et al. used criteria
composed by Robbins et al. to estimate the prevalence of
persistent MUPS, but in their study it is about the patients
who already suffer from persistent MUPS and not about
the patients at risk [4,21].
In 2010, a cross-sectional study focusing on the preva-
lence of MUPS was conducted in the Utrecht Health
Project. Patients with MUPS were identified using EMR
data in three subsequent selection steps. In our current
study we aim to validate this EMR screening method to
identify MUPS patients by comparing it to the com-
monly used and validated PHQ-15.
Methods
Setting and study population
The Utrecht Health Project is a primary care population
study with the purpose to enable research into the im-
pact of changes in health care policy, developments in
public health and quality management, as well as to sup-
port population research into determinants of health
and disease [22]. From 2000 on, all inhabitants of the
new neighbourhood Leidsche Rijn near Utrecht enlisted
with local GPs were invited to participate. Various health
measurements and questionnaires were collected after
informed consent, including the PHQ-15 since 2005,
and they were linked with follow-up data extracted from
EMRs. For our current study we were able to use EMRsfrom 1223 patients 18 years or older who completed the
PHQ-15 in 2005–2007. We retrieved EMR data for each
patient over the 12 months preceding the completion of
the PHQ-15.
Study design and procedure
In this validation study we compared the results of the
EMR screening method for detecting possible MUPS pa-
tients with the PHQ-15 scores of the patients as a refer-
ence standard. We defined patients with scores from
cut-off point ≥5 on the PHQ-15 as having MUPS, fol-
lowing Kroenke et al. [20].
The EMR screening method
The EMR screening method identifies patients with pos-
sible MUPS with three subsequent selection steps. First
step: Patients ≥18 years with ≥5 general practice consul-
tations during the past 12 months were selected, as it is
known that MUPS patients usually have relatively high
consultation rates [11]. Second step: patients with chronic
obstructive pulmonary disease, hypertension or diabetes
mellitus and patients with an established psychiatric diag-
nosis were excluded, in order to exclude all patients in
whom physical symptoms are medically explained and be-
cause frequent practice visits might at forehand be as-
sumed for these conditions [23,24].
Third step: In the remaining group, patients were se-
lected who consulted the GP with one of the three MUPS
syndromes; irritable bowel syndrome (ICPC D93), fibro-
myalgia (ICPC L18.01) and chronic fatigue syndrome
(ICPC A04.01). This group was called “Syndrome-based
Confirmed-MUPS”. Furthermore we selected all patients
who had three or more contacts with at least one of a list
of 104 ICPC codes suggestive of MUPS, as assessed by the
GPs during regular care (symptom diagnoses) (Additional
file 1). This group was called “High-risk-MUPS”. “High-
risk-MUPS” and “Syndrome-based Confirmed MUPS”
together formed the complete MUPS risk population
resulting from these selection steps.
Patient health questionnaire-15
Internationally, the PHQ-15 (Figure 1) is a widely used
and validated mental health screening instrument to as-
sess the severity of somatic symptoms. It is based on the
“Primary Care Evaluation of Mental Disorders” (PRIME-
MD), a diagnostic instrument for common mental health
disorders and the “PRIME-MD Patient Health Question-
naire” [25,26]. It inquires into 15 symptoms or symp-
toms clusters that account for more than 90 percent of
physical complaints. Thirteen somatic symptoms of the
PRIME-MD are included in the PHQ-15 and two symp-
toms are part of the PHQ depression module. For each
item, there are three options to score in severity of com-
plaints; zero (not bothered at all), one (bothered a little)
Figure 1 Patient Health Questionnaire-15.
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ging from zero to 30. For all symptoms, a score of two is
considered severe. In two studies it was concluded that
the PHQ-15 is a valid and moderately reliable question-
naire that may be used to detect MUPS. Therefore we
used this questionnaire as the reference method in our
study [20,27].
Ethical approval
All participants in the Utrecht Health Project gave in-
formed consent for linking their anonymous EMRs to
the PHQ-15. The medical ethical committee of Univer-
sity Medical Center Utrecht approved the original proto-
col of the Utrecht Health Project and its amendments
(file#99-240). The current study made use of readily
available data and did not require additional informed
consent or ethical approval.
Statistical analysis
In our dataset consisting of 1223 patients who com-
pleted the PHQ-15, we calculated the prevalence of
MUPS patients following the EMR screening method.We dichotomized the continuous PHQ-15 outcome by
using two cut-off points for mild and medium MUPS; ≥5
and ≥10 respectively, as used by Kroenke et al. [20]. Less
than 2% of all entries were missing. Missing data in the
PHQ-15 were imputed. Sensitivity analysis showed only
minor differences between complete and imputed cases.
The multiple imputation model included age, gender,
total number of contacts, all 15 PHQ-15 questions and
the outcome variable MUPS. Crosstabulations enabled
us to calculate sensitivity, specificity, predictive values
and likelihood ratios for the two cut-off points including
95% confidence intervals. All analyses were processed
with SPSS version 20.0.
Results
Prevalence of MUPS
We assessed the prevalence of the MUPS risk population
in our dataset of 1223 adult patients, consisting of 756
women (61.8%) and 467 men (38.2%) by carrying out the
described steps. The mean age was 38.8 years. Twenty-
one patients (1.7%) were identified as “Confirmed MUPS”.
All 21 were diagnosed with irritable bowel syndrome, for
Table 2 Two-by-two table of PHQ-15 cut-off point 10







Total 176 1047 1223
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12 months period. There were no patients with an ICPC
code for chronic fatigue syndrome or fibromyalgia. The
EMR screening method identified 126 patients (10.3%) as
“High-risk-MUPS”. Most patients with irritable bowel syn-
drome also had at least one ICPC code suggestive of
MUPS. Together, the total MUPS prevalence of both
groups combined in this population according to the
EMR method was 131 (10.7%). Of those, 93 (71%) were
women, significantly more than men (p = 0.04).
PHQ-15 outcomes
In the total population, 609 patients (49.8%) scored ≥5
on the PHQ-15 and 176 (14.4%) ≥10. The PHQ-15 re-
sults were skewed (skewness 1.27; Kolmogorov-Smirnov
p < 0.001) with a mean of 5.29 and a median of 4.0. In
the MUPS group selected by the EMR screening method,
102/131 (77.9%) patients scored ≥5 on the PHQ-15 and
53/131 (40.5%) scored ≥10. Again, the distribution was
skewed (skewness 0.51; Kolmogorov-Smirnov P < 0.001)
with a mean and median of 8.57 and 8.0, respectively. Of
all 21 patients with at least one contact for irritable bowel
syndrome, 19 (90.5%) scored ≥5 on the PHQ-15 and 13
(61,9%) scored ≥10.
Test characteristics of the EMR screening method
compared with the PHQ-15
For cut-off point ≥5, sensitivity and specificity of the
EMR screening method were 0.17 and 0.95, respectively.
The likelihood ratios for a positive and negative test
were 3.54 and 0.87, respectively. Positive and negative
predictive values were 78% and 54%, respectively. For
the cut-off point ≥10, sensitivity and specificity were
0.30 and 0.93, respectively. The likelihood ratio for a
positive test was 4.29, for a negative test 0.75 and posi-
tive and negative predictive values were 40% and 89%,
respectively (Tables 1, 2, and 3).
Discussion
Main findings
The aim of our study was to validate the EMR screening
method to identify MUPS patients using the PHQ-15 as
a reference test in order to map a specific and heteroge-
neous population at risk that might benefit from struc-
tured and stepped care. We found a prevalence of 10.7%
with the EMR screening method compared to a highTable 1 Two-by-two table of PHQ-15 cut-off point 5
PHQ-15 ≥ 5 PHQ-15 < 5 Total
EMR screening method ‘MUPS’ 102 29 131
EMR screening method ‘no MUPS’ 507 585 1092
Total 609 614 1223prevalence of 49.8% with the PHQ-15 cut-off ≥5. Most
MUPS patients identified by the EMR screening method
and patients with IBS scored at least 5 points on the
PHQ-15. Test characteristics showed a high specificity
but a low sensitivity for both PHQ cut-off points, which
indicates that about 80% of patients with MUPS were
missed.Interpretation of results
The prevalence of MUPS has been frequently studied
and varies greatly. In most studies, percentages range
around 30 percent in primary care [1,5,28]. In our
study, almost half of all patients scored positive on the
PHQ-15 cut-off ≥5, suggesting that many patients in this
group of patients probably have incidental complaints and
will not benefit from proactive care. The prevalence of
10.7% found by the EMR screening method is lower. The
main reason for the difference between our results and
existing literature seems to be that the EMR screening
method is rather stringent. Various other reasons can also
account for the difference. First, the quality of registration
in the participating practices may be suboptimal. In this
study, only 21 (1.7%) patients were found with an ICPC
code for irritable bowel syndrome, a much lower preva-
lence than what is known from research, namely 14 to 24
percent of women and five to 19 percent of men [29].
However, our findings are consistent with the results from
other Dutch studies in routine healthcare data [30]. We
did not find patients with a coded diagnosis of chronic
fatigue syndrome or fibromyalgia, where one or two could
be expected [31]. Patients with chronic fatigue or chronic
widespread pain, closely related to fibromyalgia, might
have been recorded with other diagnostic terms than
L18.01 (fibromyalgia) or A04.01 (chronic fatigue syn-
drome). These patients, however, will be found in the third
step of our selection where MUPS suggestive codes are
selected, such as fatigue (A04), general pain (A01) and
muscle pain (L18).
Second, we only considered ICPC codes registered dur-
ing the year preceding the patients’ PHQ-15 score. We
did not include patients with a MUPS suggestive or MUPS
syndrome ICPC code registered before that time which
could have resulted in false negatives. Finally, all
patients with known chronic somatic or psychiatric
Table 3 Comparing the EMR screening method with the PHQ-15 cut-off scores
PHQ-15≥ 5 (95% confidence interval) PHQ-15≥ 10 (95% confidence interval)
Sensitivity 0.17 (0.14 - 0.20) 0.30 (0.24 – 0.38)
Specificity 0.95 (0.93 - 0.97) 0.93 (0.91 – 0.95)
Positive predictive value 0.78 (0.71 – 0.85) 0.40 (0.32 – 0.49)
Negative predictive value 0.54 (0.51 – 0.57) 0.89 (0.87 – 0.91)
Likelihood ratio positive test 3.54 (2.38 – 5.27) 4.29 (2.96 – 5.51)
Likelihood ratio negative test 0.87 (0.84 – 0.91) 0.75 (0.69 – 0.83)
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pecially those patients more often suffer from unex-
plained symptoms [23,24].
The high specificity but low sensitivity can partly be
explained by the fact that patients do not present all
symptoms to GPs and GPs do not code all presented
symptoms in their EMRs. Furthermore, the doctor’s
diagnostic label is a reflection of the symptom the
patient presented and it is his understanding of the
situation.Strengths and limitations
Because the only selection criteria of our research popu-
lation were if they lived in a certain area (Leidsche Rijn)
and completed the PHQ-15, we minimized selection bias
and response tendencies. We had more women than
men in our study because women completed the PHQ-
15 more often than men. This is consistent with gender
differences in the number of GP encounters in the
Netherlands. We also found a significant difference be-
tween men and women in the prevalence of MUPS
which is also consistent with other studies [32,33].
Three study limitations should be noted. The first is that
no gold standard is available for defining a ‘true’ MUPS
population. In the end, only the physician decides whether
the patients’ symptoms are medically explained or not,
entailing a certain amount of subjectivity. We chose to use
the PHQ-15 because of its availability and as a second best
reference standard after the physician’s judgement as this
self-administered questionnaire has been validated for
clinical practice and research for screening and monitor-
ing MUPS and somatoform disorders by Kroenke and van
Ravensteijn [20,27]. Kroenke et al. concluded that high
total scores strongly correlate with distress, functional im-
pairment and with increased healthcare use, which sup-
ports our choice of the PHQ-15 as a reference standard.
However, Kroenke et al. noted that the PHQ-15 could not
completely replace the GPs clinical judgment as it cannot
distinguish between explained and unexplained symp-
toms. “Also, obviously using the PHQ-15 as the primary
instrument to find MUPS in primary care should not be
advised because of the high percentage found when using
cut-off point 5 or more”.Second, when registration by practice employees is not
complete and uniform according to existing guidelines
and therefore suboptimal, the performance of any EMR
search strategy will hamper. Third, MUPS are often as-
sociated with frequent attendance, but not always, par-
ticularly not in the early stages. By identifying patients
with at least 5 preceding consultations, some patients
with MUPS in the earlier stages might be missed.Implications for research and clinical practice
An accurate screening method for retrieving data from
EMRs has many advantages for research or care pur-
poses. The identified population can be offered to GPs
who should judge if their patients have MUPS or not
and should consider proactive and structured stepped
care management, depending on the severity of MUPS,
for example with panel management to prevent persist-
ence [34,35]. Looking specifically at this EMR screening
method, increasing the sensitivity while maintaining the
level of specificity will make it more suitable for pro-
active panel management. “Potential improvement might
be reached with the addition of prescription of analge-
sics or opiate drugs in patient groups without relevant
comorbidity as a predictor. Smits et al. have demon-
strated that this kind of prescription is associated with
frequent attendance [36,37]. However, in our relatively
small study population relatively few opiate drugs were
prescribed without underlying malignancy and many an-
algesics are freely available and therefore not registered,
so we were not able to include prescription of analgesics
in our analysis reliably”.Conclusion
Early identification of MUPS patients in EMRs might
support GPs to structure care and to initiate proactive
stepped care management. The assessed EMR screening
method for the identification of MUPS patients is very
specific. However, many patients with MUPS might be
missed who scored positive on the PHQ-15, used as a
reference test in our dataset. A too stringent search
strategy seems the most likely cause. Before using this
method, its sensitivity needs to be improved while main-
taining its specificity.
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